Shanghai Shen Lian Biomedical Corporation (688098.SS)
CNY 5.89
(0.68%)
CNY 5.89
(0.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.52 Million | 9.08 Million | 90.11 Million | 111.73 Million | 53.81 Million | 121.12 Million |
| Net Income | 29.85 Million | 60.97 Million | 104.45 Million | 129.36 Million | 77.95 Million | 87.58 Million |
| Depreciation & Amortization | 63.45 Million | 57.06 Million | 43.74 Million | 20.79 Million | 14.97 Million | 11.89 Million |
| Deferred income taxes | 1.06 Million | 631.05 Thousand | 1.45 Million | -4.31 Million | -123.24 Thousand | -112.1 Thousand |
| Stock-based compensation | 1.00 | - | - | 18.37 Million | - | - |
| Change in working capital | -80.69 Million | -108.11 Million | -53.24 Million | -41.03 Million | -35.35 Million | 23.77 Million |
| Other non-cash items | 17.74 Thousand | 4.67 Million | -4.84 Million | -11.45 Million | -3.76 Million | -2.12 Million |
| Investing Cash Flow | 21.86 Million | 36 Million | -127.21 Million | -90.09 Million | -630.95 Million | -77.44 Million |
| Investments in PPE | -129.63 Million | -93.12 Million | -188.16 Million | -163.56 Million | -104.08 Million | -78.8 Million |
| Acquisitions | - | 855.21 Thousand | 495.81 Thousand | 1500.00 | 104.16 Million | - |
| Investment purchases | -1.3 Billion | -1.69 Billion | -3.19 Billion | -3.61 Billion | -1.52 Billion | -533 Million |
| Sales/Maturities of investments | 1.45 Billion | 1.81 Billion | 3.25 Billion | 3.69 Billion | 993.6 Million | 535.08 Million |
| Other Investing Activities | 151.49 Million | 0.27 | 1.34 | -9999.61 | -104.08 Million | -729.81 Thousand |
| Financing Cash Flow | -33.09 Million | -36.69 Million | -32.3 Million | -63.85 Million | 371.58 Million | 196.27 Million |
| Debt repayment | -367.95 Thousand | -121.97 Thousand | -142 Thousand | -30 Million | - | -27.74 Million |
| Dividends payments | -32.85 Million | -36.95 Million | -40.97 Million | -32.77 Million | -28.77 Million | -10.47 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | -878 Thousand | - | - |
| Other Financing Activities | -320.77 Thousand | 237.22 Thousand | 8.64 Million | -1564.00 | 401.93 Million | 234.49 Million |
| Accounts receivables | -52.18 Million | -78.96 Million | -27.68 Million | -29.75 Million | -47.92 Million | 26.89 Million |
| Accounts payables | -33.15 Million | -17.88 Million | 5.25 Million | 8.55 Million | 1.06 Million | -1.77 Million |
| Inventory | 3.58 Million | -11.89 Million | -32.26 Million | -15.52 Million | 11.62 Million | -1.23 Million |
| Other working capital | -6.8 Million | 631.05 Thousand | 1.45 Million | -4.31 Million | -123.24 Thousand | 25.01 Million |
| Cash at beginning of period | 52.54 Million | 44.14 Million | 113.53 Million | 155.76 Million | 361.31 Million | 121.36 Million |
| Cash at end of period | 44.84 Million | 52.54 Million | 44.14 Million | 113.53 Million | 155.76 Million | 361.31 Million |
| Capital Expenditure | -129.63 Million | -93.12 Million | -188.16 Million | -163.56 Million | -104.08 Million | -78.8 Million |
| Effect of forex changes on cash | 35.83 | 178.63 | -45.23 | -136.84 | 34.06 | -368.82 |
| Net cash flow / Change in cash | -7.7 Million | 8.4 Million | -69.39 Million | -42.22 Million | -205.54 Million | 239.95 Million |
| Free Cash Flow | -126.1 Million | -84.03 Million | -98.04 Million | -51.83 Million | -50.27 Million | 42.32 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | -32.29 Million | -2.2 Million | -5.6 Million | 29.85 Million | 27.19 Million |
| Depreciation & Amortization | - | 17.13 Million | 17.13 Million | 63.45 Million | 63.45 Million | -29.65 Million |
| Deferred income taxes | - | - | - | - | 1.06 Million | -13.69 Million |
| Stock-based compensation | - | - | - | 1.00 | 1.00 | -817.66 Thousand |
| Change in working capital | - | -4.39 Million | - | -55.4 Million | -80.69 Million | 43.45 Million |
| Other non-cash items | - | 73.63 Million | -22.19 Million | 5.6 Million | 17.74 Thousand | -37.32 Million |
| Investing Cash Flow | -44.98 Million | 80.2 Million | 20.45 Million | -52.24 Million | 21.86 Million | -95.62 Million |
| Investments in PPE | -22.78 Million | -12.15 Million | -10.18 Million | -36.17 Million | -129.63 Million | -42.88 Million |
| Acquisitions | - | - | - | - | - | 0.53 |
| Investment purchases | -263.9 Million | -159.3 Million | -287.78 Million | -321.63 Million | -1.3 Billion | -301.9 Million |
| Sales/Maturities of investments | 241.7 Million | 251.66 Million | 318.41 Million | 305.56 Million | 1.45 Billion | 249.16 Million |
| Other Investing Activities | - | 92.36 Million | 30.63 Million | -16.06 Million | 151.49 Million | - |
| Financing Cash Flow | -1.57 Million | -13.28 Million | -80.93 Thousand | 8070.20 | -33.09 Million | -3.46 Million |
| Debt repayment | - | - | - | - | -367.95 Thousand | - |
| Dividends payments | -1.32 Million | -13 Million | - | -32.85 Million | -32.85 Million | -3.38 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -240.28 Thousand | -279.49 Thousand | -80.93 Thousand | 8070.20 | -320.77 Thousand | -84.98 Thousand |
| Accounts receivables | - | -1.94 Million | - | -52.18 Million | -52.18 Million | 37.61 Million |
| Accounts payables | - | - | - | - | -33.15 Million | 817.66 Thousand |
| Inventory | - | -2.44 Million | - | 3.58 Million | 3.58 Million | 5.84 Million |
| Other working capital | - | - | - | -6.8 Million | -6.8 Million | -817.66 Thousand |
| Cash at beginning of period | 131.32 Million | 40.8 Million | 44.84 Million | 38.87 Million | 52.54 Million | 148.81 Million |
| Cash at end of period | 98.04 Million | 131.32 Million | 40.8 Million | 44.84 Million | 44.84 Million | 38.87 Million |
| Capital Expenditure | -22.78 Million | -12.15 Million | -10.18 Million | -36.17 Million | -129.63 Million | -42.88 Million |
| Effect of forex changes on cash | -36.26 | 9.65 | 3.73 | -29.46 | 35.83 | -13.96 |
| Net cash flow / Change in cash | -33.27 Million | 90.51 Million | -4.03 Million | 5.96 Million | -7.7 Million | -109.93 Million |
| Free Cash Flow | -22.78 Million | 12.04 Million | -34.58 Million | 22.02 Million | -126.1 Million | -53.73 Million |
IZMO
TGLS
8271
CAV
DFTK
5575